PSAC Postpones Hearing with Nate Marquardt
Nate Marquardt's fate is still undecided, as the Pennsylvania State Athletic Commission postponed their hearing until next week.
The Pennsylvania State Athletic Commission was scheduled to meet Nate Marquardt last week, in relation to the fighter’s suspension due to high levels of testosterone. However, the said meeting was postponed until next week, with a decision likely to be rendered on July 13.
PSAC suspended Nate Marquardt after his pre-fight test revealed high testosterone levels. However, the fighter explained at MMAFighting.com last week that he was undergoing Testosterone Replacement Therapy (TRT) since summer of last year. Moreover, he also applied for a therapeutic care exemption in New Jersey before his UFC 128 match against Dan Miller.
Albeit Nate Marquardt was allowed to compete against Dan Miller, the New Jersey State Athletic Control Board wanted further evidence from a certified endocrinologist that the he needed TRT. In compliance with NJSACB’s request, Nate Marquardt stopped his TRT just eight weeks before his UFC Live 4 match against Rick Story. After that, the fighter took a more aggressive TRT as advised by his primary doctor.
That said, NJSACB contacted the Pennsylvania State Athletic Commission to express their concern over Nate Marquardt’s situation. The PSAC then administered a test to evaluate his testosterone level. But when the evaluation resulted high, Nate Marquardt was removed from his UFC Live 4 match, was suspended by PSAC, and was released by UFC.View Article Source »